NQO1 and cancer: Section 3.4.1 deals with NQO1 expression and establishes the strongest correlations to compound cytotoxicity. Section 3.4.2 reveals the PCCs of compounds with almost perfect direct correlations to the anti-cancer activity of known TrxR inhibitors, benzo[1,2,4]triazinones 5a–d and pleurotin.